Stocksigma LogoStocksigma Logo

Jenburkt Pharmaceuticals Equity Shares Admitted Under NSE Permitted to Trade Category

Jenburkt Pharmaceuticals informed BSE that its equity shares were admitted to dealings on NSE's Capital Market Segment under the "Permitted to Trade"

Jenburkt Pharmaceuticals Equity Shares Admitted Under NSE Permitted to Trade Category

Jenburkt Pharmaceuticals Ltd 路 Others (Uncategorized) 路 22 Sept 2026, 6:50 pm

Jenburkt Pharmaceuticals Equity Shares Admitted Under NSE Permitted to Trade Category Jenburkt Pharmaceuticals informed BSE that its equity shares were admitted to dealings on NSE's Capital Market Segment under the "Permitted to Trade" category effective 17th Aug'26, pursuant to NSE Circular dated 14th Aug'26. The company clarified that it has not applied for an NSE listing; its shares remain listed exclusively on BSE. The trading facility on NSE operates strictly under the exchange's permitted category without separate direct communication or application from the company.

Original exchange filing (PDF)

More announcements from Jenburkt Pharmaceuticals Ltd

All Jenburkt Pharmaceuticals Ltd announcements